Atlantic Sapphire ASA (LON:0AAG)
9.66
0.00 (0.00%)
At close: Aug 1, 2025
Aerovate Therapeutics Market Cap
Atlantic Sapphire ASA has a market cap or net worth of 25.08 million as of August 1, 2025. Its market cap has decreased by -28.00% in one year.
Market Cap
25.08M
Enterprise Value
53.82M
Revenue
18.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
$9.66
Market Cap Chart
Since July 12, 2017, Atlantic Sapphire ASA's market cap has decreased from 130.27M to 25.08M, a decrease of -80.75%. That is a compound annual growth rate of -18.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 25.08M | -45.36% |
Dec 30, 2024 | 45.90M | -53.89% |
Dec 29, 2023 | 99.54M | 3.77% |
Dec 30, 2022 | 95.93M | -70.35% |
Dec 30, 2021 | 323.52M | -61.15% |
Dec 30, 2020 | 832.73M | 4.48% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Jul 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.60B |
HSBC Holdings | 160.06B |
Shell | 159.31B |
Unilever | 109.82B |
Rolls-Royce Holdings | 89.38B |
British American Tobacco p.l.c. | 88.30B |
Rio Tinto Group | 76.62B |
RELX PLC | 72.00B |